glp 1 dpp 4 pathway How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics Neuroprotection by dipeptidyl-peptidase-4 inhibitors and
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

The authors connect this to something known as the rate hypothesis in addiction research: the faster a substance hits the brain, the stronger and more rewarding it feels

Here's what you need to know and how to save 10%.

Want to know if GLP-1 patches work

Celebrities credit it for their transformations, social media influencers rave about it, and doctors recognize it as a research-backed breakthrough thats changing the conversation around weight loss

Updated weekly.
